BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 19987362)

  • 21. Characteristics of circulating erythroid colony-forming cells in normal and polycythaemic man.
    Mladenovic J; Adamson JW
    Br J Haematol; 1982 Jul; 51(3):377-84. PubMed ID: 7104224
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A case of polycythaemia vera presenting with intramuscular chest wall haematoma.
    Kheterpal S; Sayegh F; Cader A
    Postgrad Med J; 1992 May; 68(799):381-2. PubMed ID: 1630988
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ropeginterferon alfa-2b versus phlebotomy in low-risk patients with polycythaemia vera (Low-PV study): a multicentre, randomised phase 2 trial.
    Barbui T; Vannucchi AM; De Stefano V; Masciulli A; Carobbio A; Ferrari A; Ghirardi A; Rossi E; Ciceri F; Bonifacio M; Iurlo A; Palandri F; Benevolo G; Pane F; Ricco A; Carli G; Caramella M; Rapezzi D; Musolino C; Siragusa S; Rumi E; Patriarca A; Cascavilla N; Mora B; Cacciola E; Mannarelli C; Loscocco GG; Guglielmelli P; Betti S; Lunghi F; Scaffidi L; Bucelli C; Vianelli N; Bellini M; Finazzi MC; Tognoni G; Rambaldi A
    Lancet Haematol; 2021 Mar; 8(3):e175-e184. PubMed ID: 33476571
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ruxolitinib for the treatment of inadequately controlled polycythaemia vera without splenomegaly (RESPONSE-2): a randomised, open-label, phase 3b study.
    Passamonti F; Griesshammer M; Palandri F; Egyed M; Benevolo G; Devos T; Callum J; Vannucchi AM; Sivgin S; Bensasson C; Khan M; Mounedji N; Saydam G
    Lancet Oncol; 2017 Jan; 18(1):88-99. PubMed ID: 27916398
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Coexistence of Polycythaemia Vera with Indolent Myeloma in the same Patient.
    Kelsey PR; Patel K
    Hematology; 1997; 2(2):139-42. PubMed ID: 27406804
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Polycythaemia vera in a dog.
    Holden AR
    Vet Rec; 1987 May; 120(20):473-5. PubMed ID: 3603998
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Peripheral gangrene as the initial manifestation of polycythaemia vera.
    Teoh PC
    Med J Aust; 1975 Apr; 1(16):504-5. PubMed ID: 1134407
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Simultaneous occurrence of multiple aetiologies of polycythaemia: renal cell carcinoma, sleep apnoea syndrome, and relative polycythaemia in a smoker with masked polycythaemia rubra vera.
    Shih LY; Wang ML; Fu JF
    J Clin Pathol; 2000 Jul; 53(7):561-4. PubMed ID: 10961184
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reno-vascular disease in polycythaemia rubra vera.
    Biggs B; Anderton JL
    Postgrad Med J; 1983 Jun; 59(692):382-3. PubMed ID: 6634546
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [A 53-year-old man with headache and concentration difficulties].
    Vik A; Berntsen R; Isaksen V; Haug E; Hansen JB
    Tidsskr Nor Laegeforen; 2005 Oct; 125(19):2647-9. PubMed ID: 16231451
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Polycythaemia Vera Presenting As A Porta Hepatis Mass.
    Ahmed S; Irfan O; Siddique S; Abid S
    J Ayub Med Coll Abbottabad; 2019; 31(4):627-628. PubMed ID: 31933324
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Splenic infarction in polycythaemia vera: can the spleen be saved?
    Inamdar S; Sangle S; Bote NN; Nagargoje N
    J Assoc Physicians India; 2014 Mar; 62(3):276-8. PubMed ID: 25327078
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Iron metabolism in polycythaemia rubra vera and secondary polycythaemia.
    Nagy G; Dezsö I; Varsányi M
    Haematologia (Budap); 1975; 9(1-2):79-84. PubMed ID: 1230402
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Acquired mutation of JAK2 tyrosine kinase and polycythaemia vera].
    Pargade V; Darnige L; Gaussem P
    Ann Biol Clin (Paris); 2006; 64(1):3-9. PubMed ID: 16420986
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A retrospective analysis of the impact of treatments and blood counts on survival and the risk of vascular events during the course of polycythaemia vera.
    Enblom-Larsson A; Girodon F; Bak M; Hersby D; Jooste V; Hasselbalch H; Johansson P; Andreasson B
    Br J Haematol; 2017 Jun; 177(5):800-805. PubMed ID: 28474342
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chorea and polycythaemia vera.
    Gribbin C; Yasmin A; Gallagher P
    Pract Neurol; 2024 Mar; 24(2):134-136. PubMed ID: 37891000
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Haematological complications in polycythaemia vera and thrombocythaemia patients treated with radiophosphorus (32P).
    Randi ML; Fabris F; Varotto L; Rossi C; Macri C; Girolami A
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(3):461-7. PubMed ID: 1703118
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 125I fibrinogen turnover in polycythaemia: the effect of phlebotomy.
    Boughton BJ; Dallinger KJ
    Br J Haematol; 1983 Jan; 53(1):97-102. PubMed ID: 6848130
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Narrowband (TL-01) ultraviolet B phototherapy for pruritus in polycythaemia vera.
    Baldo A; Sammarco E; Plaitano R; Martinelli V; Monfrecola
    Br J Dermatol; 2002 Nov; 147(5):979-81. PubMed ID: 12410710
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Qualitative platelet defect and thrombohaemorrhagic complications in a patient with polycythaemia vera. Case 10.
    Friess D; Lämmle B; Alberio L
    Hamostaseologie; 2003 Aug; 23(3):138-43. PubMed ID: 12923585
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.